US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Vaxil Bio Ltd.

0.0221

0.0000

Volume:- -

Turnover:- -

Market Cap:88.05K

PE:-24.47

High:0.0221

Open:0.0221

Low:0.0221

Close:0.0221

52wk High:0.5000

52wk Low:0.0021

Shares:3.98M

Float Shares:3.76M

Volume Ratio:0.31

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0009

EPS(LYR):-0.0009

ROE:50.07%

ROA:-10.64%

PB:0.09

PE(LYR):-24.47

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Vaxil Bio Ltd.

Exchange:

PINK LIMITED

Establishment Date:

- -

Employees:

- -

Office Location:

559 Briar Hill Avenue,Toronto,Ontario,Canada

Website:

http://www.vxlbio.com

Zip Code:

M5N 1N1

Phone:

- -

Fax:

- -

Introduction:

Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myeloma. It is also developing a tuberculosis vaccine/treatment. The company was founded in 2006 and is headquartered in Toronto, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VXLLF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VXLLF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VXLLF\",,,,,undefined,":{"symbol":"VXLLF","market":"US","secType":"STK","nameCN":"Vaxil Bio Ltd.","latestPrice":0.0221,"timestamp":1778875200000,"preClose":0.0221,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":3760332,"shares":3984021,"eps":-0.000903,"marketStatus":"Market Closed","change":0,"latestTime":"05-15 16:00:00 EDT Delay","open":0.0221,"high":0.0221,"low":0.0221,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.000903,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779091200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":0.0221,"volumeRatio":0.3105593919992447},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VXLLF\",,,,,undefined,":{"symbol":"VXLLF","floatShares":3760332,"roa":"-10.64%","roe":"50.07%","lyrEps":-0.000903,"volumeRatio":0.3105593919992447,"shares":3984021,"dividePrice":0,"high":0.0221,"amplitude":0,"preClose":0.0221,"low":0.0221,"week52Low":0.0021,"pbRate":"0.09","week52High":0.5,"institutionHeld":0,"latestPrice":0.0221,"eps":-0.000903,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.000903,"open":0.0221,"prevYearClose":0.0972,"prevWeekClose":0.0221,"prevMonthClose":0.15,"prevQuarterClose":0.11,"fiveDayClose":0.0221,"twentyDayClose":0.115,"sixtyDayClose":0.11},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VXLLF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"VXLLF","defaultRemindTime":1747315800000,"type":"split","dateTimestamp":1747281600000,"forFactor":50,"toFactor":1,"ratio":50}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VXLLF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VXLLF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":108333814,"address":"559 Briar Hill Avenue,Toronto,Ontario,Canada","zipCode":"M5N 1N1"},"stockCompanyDetail":{"websiteUrl":"http://www.vxlbio.com","stockEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":-0.0019},{"period":"3month","weight":-0.0526},{"period":"6month","weight":0.0286},{"period":"1year","weight":-0.2389},{"period":"ytd","weight":0.3433}],"description":"Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myeloma. It is also developing a tuberculosis vaccine/treatment. The company was founded in 2006 and is headquartered in Toronto, Canada.","exchange":"PINK LIMITED","name":"Vaxil Bio Ltd.","nameEN":"Vaxil Bio Ltd."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"VXLLF\",market:\"US\",,,undefined,":null}}